{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T08:32:50Z","timestamp":1694248370192},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.juro.2015.12.109","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T19:00:34Z","timestamp":1455044434000},"page":"173-178","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States"],"prefix":"10.1097","volume":"196","author":[{"given":"J. Quentin","family":"Clemens","sequence":"first","affiliation":[{"name":"University of Michigan Medical Center, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard B.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly H.","family":"Zou","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Luo","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Russell","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglass S.","family":"Chapman","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canan B.","family":"Esinduy","sequence":"additional","affiliation":[{"name":"Pfizer Inc., New York, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T.","family":"Anger","sequence":"additional","affiliation":[{"name":"Cedars Sinai Medical Center, Los Angeles, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.12.109_bib1","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/archinte.166.21.2381","article-title":"Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample","volume":"166","author":"Kupelian","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.juro.2015.12.109_bib2","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","article-title":"Urologic diseases in America project: benign prostatic hyperplasia","volume":"173","author":"Wei","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib3","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0090-4295(98)00655-4","article-title":"Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.12.109_bib5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0022-5347(05)00708-1","article-title":"Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo","volume":"175","author":"Crawford","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-4295(98)00654-2","article-title":"Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia","volume":"53","author":"Roehrborn","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.juro.2015.12.109_bib7","first-page":"1301","article-title":"Treatment of benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status","volume":"162","author":"Jacobsen","year":"1999","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2015.12.109_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.juro.2007.09.084","article-title":"The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study","volume":"179","author":"Roehrborn","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eururo.2005.09.016","article-title":"Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six European countries: report of the TRIUMPH study","volume":"49","author":"van Exel","year":"2006","journal-title":"Eur Urol"},{"issue":"suppl.","key":"10.1016\/j.juro.2015.12.109_bib11","first-page":"S99","article-title":"An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia","volume":"12","author":"Black","year":"2006","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.juro.2015.12.109_bib12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.juro.2011.04.081","article-title":"Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry","volume":"186","author":"Wei","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.12.109_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.urology.2013.09.042","article-title":"Initial treatment of men with newly diagnosed lower urinary tract dysfunction in the Veterans Health Administration","volume":"83","author":"Erickson","year":"2014","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716002718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534716002718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.12.109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:54:17Z","timestamp":1651204457000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.12.109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1016\/j.juro.2015.12.109"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.12.109","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2015.12.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}